
@{
    ViewData["Title"] = "Issue";
}

<div class="text-center"><h1>The Issue</h1></div>

<<div style="padding-bottom:75px;">

</div>


 
     <div class="row">
         <div style="padding-left: 375px;"></div>
         <div class="col-2">

             <img src="~/images/treatment.jpg" class="img-thumbnail" height="400" width="400" alt="Cinque Terre" />

         </div>

         <div class="col-2 ">
             <img src="~/images/therapy.jpg" class="img-thumbnail" height="400" width="400" alt="Cinque Terre" />

         </div>

         <div class="col-2">
             <img src="~/images/pathology.jpg" class="img-thumbnail" height="200" width="400" alt="Cinque Terre" />

         </div>

     </div>
 

<<div style="padding-bottom:75px;">

</div>

<div class="container">
    <div class="item">
        <h4>
            Twenty four million newborns develop jaundice every year, a condition in which excess
            bilirubin accumulates in blood. Preterm babies are especially susceptible because they
            lack suffecient liver function to excrete excess bilirubin. Untreated jaundice can lead
            to neurological impairment and death. Neonatal jaundice is easily treated with blue-light
            therapy, and phototherapy systems have been developed for low-resource settings. There is
            however no appropriate solution to diagnose and monitor jaundice in these settings.
            Jaundice is a major contributer to neonatal morbidity and mortality in low-resource
            settings. Each year 120,000 babies die from jaundice globally and many more suffer permanent
            neurological damage. Most of these deaths take place in low-income countries in sub-Saharan
            Africa and South Asia.

        </h4>

    </div>

</div>
